Search filters

List of works by Heikki Kuusanmäki

Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia

scientific article

Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.

scientific article published on 19 April 2018

Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia

scientific article

Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing

scientific article published on 5 May 2017

In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL.

scientific article published on 8 September 2017

Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia

scientific article published on 27 February 2014

Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testing

scientific article published on May 2015

Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia

scientific article published on 11 July 2019

Reinstated p53 response and high anti-T-cell leukemia activity by the novel alkylating deacetylase inhibitor tinostamustine

scientific article published on 25 February 2020

Selective drug combination vulnerabilities in STAT3- and TP53-mutant malignant NK cells

scientific article published on 01 April 2021

Paulina is supported by:

About Paulina

Help